ClinicalMetric / Countries / Israel / hematologic malignancy
← 🇮🇱 Israel Trials
🇮🇱 Israel Country × Condition

hematologic malignancy Clinical Trials in Israel

Active clinical trials for hematologic malignancy with research sites in Israel. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇮🇱 Israel

Active Trials in Israel (1)

NCT05735704
Recruiting

Early Detection and Screening of Hematological Malignancies - SANGUINE

Enrollment
3,000 pts
Country
🇮🇱 Israel
JaxBio Ltd
View Trial →

Frequently Asked Questions

How many hematologic malignancy clinical trials are active in Israel?
There are currently 1 active clinical trials for hematologic malignancy with sites in Israel, of which 1 are actively recruiting patients.
How can I join a hematologic malignancy clinical trial in Israel?
To join a hematologic malignancy clinical trial in Israel, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Israel directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are hematologic malignancy trials in Israel?
Active hematologic malignancy trials in Israel span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Israel Trials → Global hematologic malignancy Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology